Financials Acadia Healthcare Company, Inc.

Equities

ACHC

US00404A1097

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
71.81 ^USD	+1.87%		+8.61%	-7.65%

May. 02	Transcript : Acadia Healthcare Company, Inc., Q1 2024 Earnings Call, May 02, 2024
May. 02	Acadia Healthcare Q1 Adjusted Earnings, Revenue Increase; Reaffirms 2024 Outlook	MT

Valuation

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	2,942	4,473	5,459	7,489	7,171	6,662	-	-
Enterprise Value (EV) ¹	5,967	7,216	6,822	8,777	8,442	8,434	8,431	8,392
P/E ratio	26.8 x	-6.57 x	28.9 x	27.6 x	-324 x	20.6 x	18.4 x	16.1 x
Yield	-	-	-	-	-	-	-	-
Capitalization / Revenue	0.95 x	1.39 x	2.36 x	2.87 x	2.45 x	2.08 x	1.89 x	1.72 x
EV / Revenue	1.92 x	2.25 x	2.95 x	3.36 x	2.88 x	2.63 x	2.39 x	2.17 x
EV / EBITDA	10.2 x	11.2 x	12.2 x	14.3 x	12.5 x	11.3 x	10.2 x	9.19 x
EV / FCF	124 x	16.3 x	52.6 x	104 x	221 x	-475 x	135 x	-
FCF Yield	0.81%	6.13%	1.9%	0.96%	0.45%	-0.21%	0.74%	-
Price to Book	1.16 x	2.33 x	2.15 x	2.63 x	-	2.09 x	1.85 x	1.66 x
Nbr of stocks (in thousands)	88,570	88,991	89,936	90,977	92,216	92,775	-	-
Reference price ²	33.22	50.26	60.70	82.32	77.76	71.81	71.81	71.81
Announcement Date	2/27/20	2/25/21	2/28/22	2/27/23	2/27/24	-	-	-

¹USD in Million²USD

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	3,107	3,210	2,314	2,610	2,929	3,206	3,526	3,864
EBITDA ¹	585.9	644.1	558.7	615.1	677.7	749.4	828.5	913.3
EBIT ¹	404.5	548.9	452	475.9	545.3	572.7	635.2	708.4
Operating Margin	13.02%	17.1%	19.53%	18.23%	18.62%	17.86%	18.02%	18.34%
Earnings before Tax (EBT) ¹	136	-626.2	275.8	374.1	-25.36	428.5	482.4	564.7
Net income ¹	108.9	-672.1	190.6	273.1	-21.67	325.6	367.3	417.4
Net margin	3.51%	-20.94%	8.24%	10.46%	-0.74%	10.16%	10.42%	10.8%
EPS ²	1.240	-7.650	2.100	2.980	-0.2400	3.492	3.894	4.460
Free Cash Flow ¹	48.22	442.2	129.7	84.42	38.21	-17.74	62.64	-
FCF margin	1.55%	13.78%	5.6%	3.23%	1.3%	-0.55%	1.78%	-
FCF Conversion (EBITDA)	8.23%	68.65%	23.21%	13.72%	5.64%	-	7.56%	-
FCF Conversion (Net income)	44.27%	-	68.02%	30.91%	-	-	17.05%	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Announcement Date	2/27/20	2/25/21	2/28/22	2/27/23	2/27/24	-	-	-

¹USD in Million²USD

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2
Net sales ¹	593.5	616.7	651.7	666.7	675.3	704.3	731.3	750.3	742.8	768.1	793.1	822.4	820	842.6	868.1
EBITDA ¹	156.1	135.5	157.3	155.1	150.9	151.3	174.5	175.9	171.6	173.9	191.1	193.9	190.6	191.4	213.1
EBIT ¹	127.7	106.6	128.2	125.5	115.5	119.7	142.5	142.5	136.2	137.6	146.8	149.6	144.3	145.8	166.8
Operating Margin	21.52%	17.29%	19.67%	18.83%	17.11%	17%	19.48%	18.99%	18.33%	17.91%	18.51%	18.19%	17.6%	17.31%	19.21%
Earnings before Tax (EBT) ¹	96.13	79.31	109.7	97.1	88.07	85.64	96.43	-287.4	79.96	98.84	115.1	112.6	97.92	113.4	135.2
Net income ¹	70.28	60.84	80.08	71.1	61.12	66.02	72.3	-217.7	57.73	76.38	86.53	86.15	76.69	82.35	100.8
Net margin	11.84%	9.87%	12.29%	10.66%	9.05%	9.37%	9.89%	-29.02%	7.77%	9.95%	10.91%	10.48%	9.35%	9.77%	11.61%
EPS ²	0.7700	0.6700	0.8800	0.7800	0.6700	0.7200	0.7900	-2.390	0.6300	0.8300	0.9320	0.9260	0.8100	0.8850	1.057
Dividend per Share ²	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Announcement Date	2/28/22	5/3/22	7/27/22	10/31/22	2/27/23	4/26/23	7/27/23	11/2/23	2/27/24	5/1/24	-	-	-	-	-

¹USD in Million²USD

Estimates

Balance Sheet Analysis

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	3,025	2,744	1,363	1,288	1,272	1,772	1,769	1,730
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	5.163 x	4.26 x	2.44 x	2.094 x	1.877 x	2.365 x	2.135 x	1.894 x
Free Cash Flow ¹	48.2	442	130	84.4	38.2	-17.7	62.6	-
ROE (net income / shareholders' equity)	7.4%	11.2%	8.63%	10.9%	11.4%	11%	11%	11%
ROA (Net income/ Total Assets)	2.74%	3.68%	3.38%	5.97%	6.19%	5.75%	5.9%	6.32%
Assets ¹	3,968	-18,264	5,634	4,579	-350.1	5,662	6,230	6,610
Book Value Per Share ²	28.60	21.60	28.30	31.30	-	34.40	38.90	43.20
Cash Flow per Share ²	3.790	7.440	4.120	4.160	5.080	3.610	6.060	6.960
Capex ¹	285	217	245	296	424	560	539	536
Capex / Sales	9.16%	6.75%	10.58%	11.34%	14.48%	17.45%	15.3%	13.87%
Announcement Date	2/27/20	2/25/21	2/28/22	2/27/23	2/27/24	-	-	-

¹USD in Million²USD

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Acadia Healthcare Company, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

71.81 USD

Average target price

88.92 USD

Spread / Average Target

+23.82%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
ACADIA HEALTHCARE COMPANY, INC.	-7.65%	6.66B
HCA HEALTHCARE, INC.	+20.68%	85.55B
CVS HEALTH CORPORATION	-29.31%	70.07B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+9.72%	29.06B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-8.63%	17.51B
FRESENIUS SE & CO. KGAA	+2.14%	17.39B
QUEST DIAGNOSTICS INCORPORATED	+0.39%	15.38B
REDE D'OR SÃO LUIZ S.A.	+6.47%	13.4B
NATERA, INC.	+68.09%	12.87B
FRESENIUS MEDICAL CARE AG	+6.43%	12.77B

Other Healthcare Facilities & Services